Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alberto, Zori Comba"'
Autor:
Graciela Caccia, Jeannette Rodger, Celia Brosio, Elizabeth Mickiewicz, Luis Riva Gonzáles, Luis Balbiani, Daniel Flores Morales, Carlos Delfino, Alberto Zori Comba
Publikováno v:
Oncology. 66:18-23
Objectives: To assess the efficacy and tolerability of gemcitabine and paclitaxel as first-line treatment in advanced breast cancer. Methods: Patients with histologically confirmed metastatic or metastatic plus locally advanced breast cancer received
Autor:
Carlos, Delfino, Graciela, Caccia, Luis, Riva Gonzáles, Elizabeth, Mickiewicz, Jeannette, Rodger, Luis, Balbiani, Daniel, Flores Morales, Alberto, Zori Comba, Celia, Brosio
Publikováno v:
Oncology (Williston Park, N.Y.). 17(12 Suppl 14)
Gemcitabine (Gemzar) and paclitaxel exhibit good activity and good safety profiles when used alone and together in the treatment of advanced breast cancer. In a phase II trial, 45 patients with metastatic breast cancer received gemcitabine at 1,200 m
Autor:
Fernando Otero, José Milei, J. J. Ale, Guy Garay, Humberto O. Gugliotta, R. Storino, Alberto Zori Comba
Publikováno v:
Cardiovascular drugs and therapy. 4(6)
Adriamycin (ADM) is an effective antineoplastic drug. However, the amount of ADM that can be administered must be limited because of the risk of developing a severe dose-dependent cardiomyopathy. 4'Epi-adriamycin (4'ADM) is a new anthracycline analog